Vertex Pharmaceuticals (VRTX) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Vertex Pharmaceuticals (VRTX) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.41% |
| Dec 31, 2025 | 9.99% |
| Sep 30, 2025 | 4.84% |
| Jun 30, 2025 | 59.82% |
| Mar 31, 2025 | -29.21% |
| Dec 31, 2024 | -12.67% |
| Sep 30, 2024 | 129.09% |
| Jun 30, 2024 | -426.81% |
| Mar 31, 2024 | 13.50% |
| Dec 31, 2023 | -6.42% |
| Sep 30, 2023 | 13.06% |
| Jun 30, 2023 | 30.85% |
| Mar 31, 2023 | -14.54% |
| Dec 31, 2022 | -11.99% |
| Sep 30, 2022 | 14.81% |
| Jun 30, 2022 | 6.35% |
| Mar 31, 2022 | -1.04% |
| Dec 31, 2021 | -9.60% |
| Sep 30, 2021 | 1,171.49% |
| Jun 30, 2021 | -89.74% |